4967:TSEKobayashi Pharmaceutical Co., Ltd. Analysis

Team Group Inc. is trading at TWD 208.5, comfortably above its 20‑day (199.85) and 50‑day (202.89) simple moving averages but still well below the 200‑day average of 122.5, indicating a short‑term price strength that has not yet translated into a longer‑term uptrend. Technical indicators are mixed: the RSI sits at a neutral 54.6, while the MACD shows a bearish divergence with the line below the signal, suggesting potential downside pressure as the price approaches the identified resistance of 233. Volatility is high at 75.9% over the past 30 days, and the beta of 0.51 points to lower systematic risk than the market, yet the stock remains exposed to sector‑specific swings. On the valuation side, the trailing P/E of 16.1 is well under the industry average of 34.3, positioning the stock as undervalued relative to peers, though a price‑to‑book of 3.66 signals a premium on assets. The company delivers a solid ROE of 25% and a modest dividend yield of 1.52% with a low payout ratio of 23%, but negative operating and free cash flow coupled with a debt‑to‑equity of 66.7% raise concerns about the sustainability of the dividend and balance‑sheet resilience. Overall, the blend of attractive valuation and strong profitability is tempered by cash‑flow weakness, high volatility, and a neutral technical outlook, suggesting a cautious but potentially rewarding investment case.